Cadrenal Therapeutics, Inc. · NASDAQ:CVKD
John Raymond Murphy's stake in Cadrenal Therapeutics, Inc. fell to 2.96% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 15, 2025
John Raymond Murphy's stake in Cadrenal Therapeutics, Inc. fell to 2.96%, 53,205 shares, as a passive investor on Dec 31, 2024. Filed Jan 15, 2025 (Schedule 13G/A).
- Stake
- 2.96%
- Shares
- 53,205
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| John Raymond Murphy | 2.96% | 53,205 |